AIVITA Biomedical CEO Dr. Hans Keirstead to Deliver Keynote at World Immunotherapy Congress Europe
IRVINE, Calif. – Nov. 1, 2022 – AIVITA Biomedical, Inc., a biotech company specializing in innovative stem cell applications,…
AIVITA Biomedical CMO Dr. Robert Dillman to Deliver Keynote at Vaccines Summit 2022
IRVINE, Calif. – Oct. 12, 2022 – AIVITA Biomedical, Inc., a biotech company specializing in innovative stem cell applications,…
AIVITA Biomedical Announces Publication Detailing 50% Enhanced Survival in Phase 2 GBM Study
IRVINE, Calif. – Oct. 4, 2022 – AIVITA Biomedical, Inc., a biotech company specializing in innovative cell applications, today…
AIVITA Biomedical CEO Dr. Hans Keirstead Wins Innovator of the Year Award
IRVINE, Calif. – Sep. 13, 2022 – AIVITA Biomedical, Inc., a biotech company specializing in innovative cell applications, today…
AIVITA Biomedical CEO Dr. Hans Keirstead to Deliver Keynote Address at United Nations ‘AI for Good’ Meeting
IRVINE, Calif. – Sep. 13, 2022 – AIVITA Biomedical, Inc., a biotech company specializing in innovative cell applications, today…
AIVITA Biomedical Announces Publication of Phase 1 and Phase 2 Trial Results of its COVID-19 Vaccine Candidate
Personal vaccine made at point-of-care generated enhanced T-cell responses in 96.8% of evaluable subjects within 28 days Immediate and…
AIVITA Biomedical Appoints Dr. H. Christian Fibiger to its Board of Directors
IRVINE, Calif. – Apr. 5, 2022 – AIVITA Biomedical, Inc., a biotech company specializing in innovative stem cell applications,…
AIVITA Biomedical CEO Dr. Hans Keirstead to Deliver Keynote at Festival of Biologics
IRVINE, Calif. – Mar. 9, 2022 – AIVITA Biomedical, Inc., a biotech company specializing in innovative stem cell applications,…
AIVITA Biomedical CEO Dr. Hans Keirstead to Deliver Keynote At Vaccine World Asia Congress
IRVINE, Calif. – Nov. 16, 2021 – AIVITA Biomedical, Inc., a biotech company specializing in innovative stem cell applications,…
AIVITA Biomedical CEO Dr. Hans Keirstead to Chair Keynote Panel and Deliver Talk at World Immunotherapy Congress Europe
IRVINE, Calif. – Nov. 8, 2021 – AIVITA Biomedical, Inc., a biotech company specializing in innovative stem cell applications,…
